Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

The Cambridge University Hospitals and Anglia Regional Experience of Using PEP-C As Palliative Chemotherapy in Lymphoma

Simon J Bulley, Isabel C Lentell, Brendan O'Sullivan, Annabel M Follows, Shalal Sadullah, Mamatha Karanth, MD, Sandra Young Min, James Russell, MA,MBBChir,MRCP, Benjamin J Uttenthal, MD PhD, George A Follows, MD PhD

Blood (2017) 130 (Supplement 1): 4157.

https://doi.org/10.1182/blood.V130.Suppl_1.4157.4157

Published: 2017

Journal Articles

Advanced-Stage Hodgkin Lymphoma in the East of England Cancer Network: A 10-Year Comparative Analysis of Outcomes for Patients Treated with ABVD or Escalated BEACOPP in the Non-Trial Setting Compared with Age-Matched Patients Treated in the Multinational RATHL Trial

James Russell, MD, Angela Collins, MD, Alexis Fowler, MD, Mamatha Karanth, MD, Isabel Lentell, MD, Chandan Saha, MD, Suzanne Docherty, MD, Joseph Padayatty, MD, Kyaw Maw, MD, Lisa Cooke, MD, Andrew Hodson, MD, Nimish Shah, MD, Shalal Sadullah, MD, Nicholas Grigoropoulos, MD PhD, Wendi Qian, Amy A Kirkwood, Benjamin J Uttenthal, MD PhD, Peter Johnson, MD FRCP, George A Follows, MD PhD

Blood (2017) 130 (Supplement 1): 735.

https://doi.org/10.1182/blood.V130.Suppl_1.735.735

Published: 2017

Journal Articles

REDX08608, a Novel, Potent and Selective, Reversible BTK Inhibitor with Efficacy and Equivalent Potency Against Wild-Type and Mutant C481S BTK

Blood (2016) 128 (22): 4399.

https://doi.org/10.1182/blood.V128.22.4399.4399

Published: 2016

Journal Articles

Efficacy of Oral Ciprofloxacin Prophylaxis in BMT Recipients: A Case-Control Study.

Pedro R. Camacho, MD-R, James Russell, MD, Karen Shepard, RN, Diana Quinlan, RN, Jan Mclaughlin, RN

Blood (2007) 110 (11): 4987.

https://doi.org/10.1182/blood.V110.11.4987.4987

Published: 2007

Journal Articles

Improving the Pharmacokinetic Analysis of the Once Daily IV Busulfan Regimen for Allogeneic Stem-Cell Transplants: A Scientific Method Modification.

Farrukh Naveed, BSc, Shahbal Kangarloo, BSc, MSc, Ahsan Chaudhry, BSc, MD, Michelle Geddes, BSc, MD, Diana Quinlan, RN, BN, CCRP, James Russell, MA, MB, BChir, FRCPE

Blood (2006) 108 (11): 2941.

https://doi.org/10.1182/blood.V108.11.2941.2941

Published: 2006

Journal Articles

IV Busulfan (Bu) with Fludarabine (Flu) or Cyclophosphamide (Cy) - Comparing Ablative Conditioning Regimens for Allogeneic Transplantation in AML/MDS.

Marcos de Lima, Daniel Couriel, Munir Shahjahan, Jorge Alamo, Peter F. Thall, James Russell, Paolo Anderlini, Sergio Giralt, Elizabeth J. Shpall, Roy B. Jones, Richard E. Champlin, Borje S. Andersson

Blood (2004) 104 (11): 97.

https://doi.org/10.1182/blood.V104.11.97.97

Published: 2004

Journal Articles

Incidence and Outcome of Hepatic Veno-Occlusive Disease After Blood or Marrow Transplantation: A Prospective Cohort Study of the European Group for Blood and Marrow Transplantation

Blood (1998) 92 (10): 3599–3604.

https://doi.org/10.1182/blood.V92.10.3599

Published: 1998

NARROW

The Cambridge University Hospitals and Anglia Regional Experience of Using PEP-C As Palliative Chemotherapy in Lymphoma

Advanced-Stage Hodgkin Lymphoma in the East of England Cancer Network: A 10-Year Comparative Analysis of Outcomes for Patients Treated with ABVD or Escalated BEACOPP in the Non-Trial Setting Compared with Age-Matched Patients Treated in the Multinational RATHL Trial

REDX08608, a Novel, Potent and Selective, Reversible BTK Inhibitor with Efficacy and Equivalent Potency Against Wild-Type and Mutant C481S BTK

Efficacy of Oral Ciprofloxacin Prophylaxis in BMT Recipients: A Case-Control Study.

Improving the Pharmacokinetic Analysis of the Once Daily IV Busulfan Regimen for Allogeneic Stem-Cell Transplants: A Scientific Method Modification.

IV Busulfan (Bu) with Fludarabine (Flu) or Cyclophosphamide (Cy) - Comparing Ablative Conditioning Regimens for Allogeneic Transplantation in AML/MDS.

Incidence and Outcome of Hepatic Veno-Occlusive Disease After Blood or Marrow Transplantation: A Prospective Cohort Study of the European Group for Blood and Marrow Transplantation

Email alerts

ASH Publications

American Society of Hematology

The Cambridge University Hospitals and Anglia Regional Experience of Using PEP-C As Palliative Chemotherapy in Lymphoma

Advanced-Stage Hodgkin Lymphoma in the East of England Cancer Network: A 10-Year Comparative Analysis of Outcomes for Patients Treated with ABVD or Escalated BEACOPP in the Non-Trial Setting Compared with Age-Matched Patients Treated in the Multinational RATHL Trial

REDX08608, a Novel, Potent and Selective, Reversible BTK Inhibitor with Efficacy and Equivalent Potency Against Wild-Type and Mutant C481S BTK

Efficacy of Oral Ciprofloxacin Prophylaxis in BMT Recipients: A Case-Control Study.

Improving the Pharmacokinetic Analysis of the Once Daily IV Busulfan Regimen for Allogeneic Stem-Cell Transplants: A Scientific Method Modification.

IV Busulfan (Bu) with Fludarabine (Flu) or Cyclophosphamide (Cy) - Comparing Ablative Conditioning Regimens for Allogeneic Transplantation in AML/MDS.

Incidence and Outcome of Hepatic Veno-Occlusive Disease After Blood or Marrow Transplantation: A Prospective Cohort Study of the European Group for Blood and Marrow Transplantation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only